Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside revenue and earnings rise as chief executive steps down
21 Nov 2019 - UK Earnings, Trading Statements Calendar - Next 7 Days
14 Nov 2019 - Sigma Capital Acquires Two East London Development Sites
8 Oct 2019 - UK Earnings, Trading Statements Calendar - Next 7 Days
3 Oct 2019 - Tuesday broker round-up
1 Oct 2019 - BROKER RATINGS SUMMARY: Bank Of America Says Buy IAG, Wizz And Ryanair
1 Oct 2019 - BROKER RATINGS SUMMARY: Jefferies Cuts Taylor Wimpey And Barratt
27 Sep 2019 - BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy
3 Sep 2019
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside revenue and earnings rise as chief executive steps down
(Sharecast News) - Countryside Properties reported 5,733 completions in its 2019 financial year on Thursday, up 33% from the 4,295 completions it achi...
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Sigma Capital Acquires Two East London Development Sites
Sigma Capital Acquires Two East London Development Sites
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Tuesday broker round-up
(Sharecast News) - Carnival: Barclays downgrades to equal weight with a target price of 3,800p.
BROKER RATINGS SUMMARY: Bank Of America Says Buy IAG, Wizz And Ryanair
BROKER RATINGS SUMMARY: Bank Of America Says Buy IAG, Wizz And Ryanair
BROKER RATINGS SUMMARY: Jefferies Cuts Taylor Wimpey And Barratt
BROKER RATINGS SUMMARY: Jefferies Cuts Taylor Wimpey And Barratt
BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:----------FTSE 100----------DEUTSCHE BANK INITIA...
Follow the stocks
